Structural Roadmap Elements: Building the Backbone of ACS GCIPR 2045 Strategy

The ACS GCI Pharma Roundtable has been designing a Roadmap for NetZero/Sustainable Medicines. The focus will be to define a path to produce Net-Zero Active Pharmaceutical Ingredients (API) while minimizing other hazards to human health and the environment within the next two decades. The areas to be covered are: 1. Circularity & Renewable Chemicals 2. More Efficient Synthetic Methods 3. Safer Synthetic Conditions & Substances 4. Process Intensification & Electrification 5. Metrics & Decision-Making Presentations on how this will be achieved by including the work of the focus teams and collaborations with academics, government and other consortia.

Hanno Erythropel, Ph.D., Yale University

Lars Ratjen

Paul Anastas, Yale University

Peter Licence, The University of Nottingham

Hanno Erythropel, Ph.D., Yale University

Lars Ratjen

Paul Anastas, Yale University

Peter Licence, The University of Nottingham